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ABSTRACT
Objective: The objective of this systematic EBM review is to determine “Is Cryotherapy with
Exercise Therapy More Effective than Exercise Therapy Alone in Reducing Symptoms
Associated with Ankylosing Spondylitis?”
Study Design: A comprehensive review of three randomized controlled trials (RCTs).
Data Sources: PubMed database was used to find all three articles referenced in this review.
Each article was published in a peer-reviewed journal and published after 2010.
Outcome Measured: The outcome considered for this review was subjective reduction in
disease activity measured using the Bath Ankylosing Spondylitis Disease Activity Index
(BASDAI) which consists of 6 questions regarding clinical manifestations of AS. BASDAI was
calculated using a numerical rating scale of 0 (no symptoms) to 10 (very severe).
Results: Stanek et al. demonstrated a greater reduction in disease activity after intervention with
cryotherapy compared to exercise therapy alone, with the difference in ending BASDAI being
1.4 and a p-value of 0.001. Straburzyńska-Lupa et al. also demonstrated statistical significance of
cryotherapy over exercise therapy, although the difference in ending BASDAI was not as large at
0.39, and a p-value of 0.041. Księżopolska-Orłowska et al. demonstrated not only greater
significance of cryotherapy over exercise therapy directly post trial, but also lasting significant
reduction in BASDAI three months post-trial, with a p-value of < 0.001 at the three-month mark,
compared to the exercise therapy only group which did not demonstrate significance at this
assessment.
Conclusion: All three RCTs considered in this study showed cryotherapy in addition to exercise
therapy resulted in a statistically significant greater reduction in symptomatic disease activity as
compared to exercise therapy alone. Several limitations were identified, and further studies are
warranted to confirm validity, however systemic cryotherapy demonstrates significant potential
as a therapeutic agent in the treatment of AS.
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Introduction
Ankylosing spondylitis (AS) is a highly genetic rheumatic disease that targets the axial
skeleton. This disease manifests as inflammatory destruction of the bone tissue and subsequent
abnormal bony growths, leading to fusion of vertebrae, commonly referred to as “bamboo
spine.” Clinically, AS causes pain of the back and hips, impairment in spinal mobility, and
postural abnormalities.1 The modified New York criteria for diagnosing AS has a clinical and
radiological component. Clinical criteria includes either low back pain for more than 3 months
that is improved by exercise and not relieved by rest, limitation of lumbar spine in sagittal and
frontal planes, or limitation of chest expansion. Radiologic criteria includes bilateral grade 2-4
sacroiliitis or unilateral grade 3-4 sacroiliitis.1 Based on a 2012 study, the estimated prevalence
of AS in the US is 0.5%. AS is strongly associated with the expression of HLA-B27, which has a
prevalence of 6.1% amongst individuals in the US.2 The rate of HLA-B27 expression in
populations around the world can predict the prevalence of AS in those communities. Prevalence
is highest amongst non-Hispanic Caucasian men between the ages of 20-75.1 The average ASspecific healthcare cost for a patient in the US was estimated to be $16,337 annually, based on a
2018 retrospective study, and included inpatient services, outpatient services, and pharmacy
costs.3 Minimal studies regarding healthcare utilization for patients with AS have been done,
however one study comparing veterans with AS to unaffected veterans showed an increase of 86140% in use of outpatient primary care, subspecialty, and surgical centers. 4
AS manifests as a result of genetic and environmental factors. The role of HLA-B27 in
the pathogenesis of AS is well studied and considered the most significant genetic risk factor. It
is theorized that expression of this genetic variation can lead to malformation of its target protein
causing a proinflammatory state as well as lead to formation of dimers recognized by NK cells.5
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However, cases of AS in patients without this variation are plentiful, leaving the question of
which other genetic variations are causing susceptibility.5 Some current research is focused on
how disruptions in the gut microbiome may play a role in exacerbation of rheumatic diseases like
AS, but the mechanisms of this phenomenon remain unknown, although could be a target for
therapy in the future.5 Current treatments for AS aim to relieve symptoms and maintain function
of the spine and pelvis by combining pharmacotherapy with physical and exercise therapy.
NSAIDs such as naproxen and ibuprofen are considered first line and utilized to control pain and
inflammation.6 Other pharmacologic agents include DMARDs such as methotrexate or
sulfasalazine.6 TNF inhibitors and interleukin 17 inhibitors are reserved for refractory cases.6
NSAIDs are the mainstay of AS treatment. While they do provide temporary relief of
pain, they do little in terms of stiffness and spinal mobility, and long-term use of NSAIDs can
lead to peptic ulcer disease, renal dysfunction, and cardiovascular events. Cryotherapy is
theorized to reduce intra-joint temperature, which subsequently reduces the activity of
proinflammatory cytokines and enzymatic pathways, white blood cell infiltration, and oxidative
stress.7 When used systemically, it has shown effective in reducing inflammation, improving
stiffness and pain in other rheumatic diseases. Paired with exercise therapy, cryotherapy has the
potential to improve the quality of life in patients with AS. This review compares the results
from three randomized controlled trials (RCTs) to assess if cryotherapy made an impact on the
symptomatic disease manifestations in patients with AS.
Objective
The objective of this systematic EBM review is to determine “Is Cryotherapy with
Exercise Therapy More Effective than Exercise Therapy Alone in Reducing Symptoms
Associated with Ankylosing Spondylitis?”
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Methods
Trials for this review were selected based on their relevance in answering the proposed
question involving a patient-oriented outcome. Each study came from a credible, peer-reviewed
journal. The patient population of interest was adults diagnosed with ankylosing spondylitis
using the modified New York criteria for AS. The intervention of interest was full body
cryotherapy in addition to exercise therapy, compared to exercise therapy alone. The outcome of
interest was subjective reduction in disease activity. Only studies fitting the above criteria were
selected for review.
Research was conducted using PubMed with the key words “ankylosing spondylitis” and
“cryotherapy.” The inclusion criteria were a publication date after 2010, English as the language,
and randomized control trial as article type. The exclusion criteria were studies published before
2010 and studies involving patients with a secondary rheumatic disease. The studies used in this
review reported statistical significance by using mean change from baseline in the Bath
Ankylosing Spondylitis Disease Activity Index (BASDAI) and p-value analysis. The
demographics and inclusion characteristics from each study are listed in Table 1.
Outcome Measured
The outcome of each study considered in this review was subjective reduction in disease
activity using the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). The BASDAI
consist of 6 questions regarding severity of fatigue, pain in the neck, back and hips, pain and
swelling of peripheral joints, tenderness, and morning stiffness.9 Participates answered these
questions using a numerical rating scale of 0 (no symptoms) to 10 (very severe).9
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Table 1. Demographics & Characteristics of Included Studies
Study

Type

# Pts

Age
(yrs)

Inclusion
Criteria

Exclusion
Criteria

Straburzyń
ska-Lupa8
(2018)

RCT

44

Stanek9
(2018)

RCT

Księżopols
kaOrłowska10
(2016)

RCT

W/
D

Interventions

3963

BASDAI ≥ 4,
stable medication
regimen of
NSAIDs and
corticosteroids at
the equal dose for 2
weeks, DMARDS
before the start of
the study and for
the duration of the
study, and w/o
corticosteroids
within 4 weeks
before.

Treatment with
biological agents,
tobacco use, and
contraindications
to cryotherapy.

0

Whole body
cryotherapy
with exercise
therapy vs.
exercise
therapy alone

32

4548

Male patients
diagnosed with AS,
HLA
B27-positive, who
exhibited II and III
radiographic
grades of sacroiliac
joint disease,
treated with
NSAIDs unaltered
for 1 month before
and during the
study.

Diagnosis of any
other disease or
pathology; use of
DMARDs,
biologic agents or
steroids.

0

Whole body
cryotherapy
with exercise
therapy vs.
exercise
therapy alone

50

2958

Patients diagnosed
with AS based on
the modified New
York criteria,
criteria for axial
SpA, and
criteria for
peripheral SpA

Unemployed
individuals,
females,
contraindications
to cryotherapy.

0

Systemic and
local
cryotherapy
with exercise
therapy vs.
conventional
exercise
therapy alone
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Results
Straburzyńska-Lupa et al. conducted a study involving 65 adults diagnosed with AS to
determine the effect of adding whole body cryotherapy (WBC) to the treatment regimen for AS
on symptomatic disease activity. The study was conducted through the Poznan University of
Medical Sciences in Poznań, Poland in 2017. Participants were on a steady medication regimen
of DMARDs unaltered throughout the trial.8 The study involved two experimental and one
control group, however this review only considers the outcome from the experimental group who
underwent WBC at −110°C. Participants were randomly placed into each group but were not
blinded to intervention due to the nature of the study. There was no significant difference
between starting BASDAI (p = 0.490).8 The experimental group consisted of 23 patients who
underwent 3 minutes of WBC at −110°C in a cryogenic electric chamber wearing only bathing
suits. Cryotherapy was proceeded by 30 minutes of exercise therapy.8 The control group
consisted of 21 patients who participated in exercise therapy only. Both groups participated in
the same general rehabilitation exercise session for 30 minutes, focusing on cardiovascular and
range of motion exercises to reduce stiffness.8 The trial was completed over an 8-day period,
with a break on Saturday and Sunday. All participants completed the study without
complication.8
Effect on disease activity was measured using the BASDAI one day before the start of
the trial and one day after. At the completion of the trial, mean change in BASDAI of each group
were calculated and compared as well as evaluated for significance using p-value analysis. Both
interventions resulted in significant reduction in disease activity. The WBC group had a mean
reduction in BASDAI of 1.62 with a p-value of 0.0001.8 The exercise therapy group had a mean
reduction in BASDAI of 1.23 with a p-value of 0.0007.8 Cryotherapy in addition to exercise
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therapy resulted in a slightly greater reduction in BASDAI, compared to exercise therapy only.
The difference between mean change was 0.39 with a p-value of 0.041.8 Results can be found in
Table 2.
Table 2. BASDAI Change in Disease Activity Before and After Intervention8
Group
Before
After Intervention
Mean Change
P-value
Intervention
from Baseline
(Mean ± SD)
(Mean ± SD)
WBC + exercise 5.39 ± 1.12
-1.62
0.0001
3.77 ± 1.56
therapy
Exercise therapy 5.83 ± 1.29
-1.23
0.0007
4.6 ± 1.72
alone
Mean change
0.39
0.041
comparison
Stanek et al. conducted a study involving 32 adult males diagnosed with AS according to
the modified New York Criteria to assess the effect of WBC on symptomatic disease activity.
The study took place at the Medical University of Silesia in Katowice, Poland in 2016. All
participants had similar starting BASDAI, BMI, and absence of comorbidities.9 They were on the
same medication regimen consisting of only NSAIDs, unaltered throughout the duration of the
study.9 Participants were randomly allocated into the experimental and control group, though
were unable to be blinded to intervention. There was no significant difference between starting
BASDAI (p = 0.720).9 The experimental group consisted of 16 patients who underwent 3
minutes of WBC at −120°C proceeded by 60 minutes of exercise therapy.9 The control group
consisted of 16 patients who underwent 60 minutes of exercise therapy only.9 Exercise therapy
was the same for both groups, primarily focusing on range of motion and aerobic exercises. The
trial lasted 10 days, excluding Sunday and Saturday. All participants completed the study
without complications with either intervention.9
Symptomatic disease activity was stratified by measuring BASDAI one day prior to and
one day after succession of the study. At the completion of the trial, change in BASDAI was
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calculated and compared between groups, as well as assessed for significance using p-value
analysis. Reduction in BASDAI was significant in both the WBC and exercise therapy groups.
The WBC group resulted in a mean reduction in BASDAI of 2.14 with a p-value of < 0.001.9
The exercise therapy group had a mean reduction in BASDAI of 0.74 with a p-value of < 0.001.9
Cryotherapy allowed for a significantly greater reduction in disease activity; the difference
between mean change in BASDAI was 1.4 with a p-value of 0.001.9 Results can be found in
Table 3.
Table 3. BASDAI Change in Disease Activity Before and After Intervention9
Group
Before
After Intervention
Mean Change
P-value
Intervention
from Baseline
(Mean ± SD)
WBC + exercise 5.43 ± 1.61
- 2.14
< 0.001
3.29 ± 0.91
therapy
Exercise therapy 5.28 ± 1.71
- 0.74
< 0.001
4.53 ± 1.62
alone
Mean change
1.4
0.001
comparison
Księżopolska-Orłowska et al. conducted a study consisting of 50 male patients diagnosed
with AS based on the modified New York criteria to compare the efficacy of cryotherapy in
reduction musculoskeletal disease activity. The study was conducted at the Rheumatology
Institute in Warsaw, Poland in 2015. All patients were on a medication regimen of NSAIDs
while 42% were additionally on either corticosteroids or DMARDs and 18% were on biological
therapy.10 Medication regimens were unaltered throughout the duration of the study.10
Participants were randomly allocated into two groups but were unable to be blinded to
intervention. There was no significant difference between starting BASDAI (p = 0.564).10 The
experimental group consisted of 25 patients who underwent systemic and local cryotherapy
followed by general rehabilitation exercise therapy.10 Duration and means of cryotherapy were
not reported. The control group consisted of 25 patients who participated in only the general
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rehabilitation exercises.10 These interventions were conducted 3 times a week for 45-minutes
total for 3 consecutive weeks. All participants completed the study without complication.10
Participants were evaluated using the BASDAI prior to the start of the study, after
completion, and at 3 months post trial. Results were assessed using change in BASDAI which
was compared between experimental and control group. Reduction in BASDAI immediately
after the trail was significant in both groups. The cryotherapy-based group resulted in a BASDAI
reduction of 2.76 with a p-value of < 0.001.10 The exercise therapy group had a reduction in
BASDAI of 1.66 with a p-value of < 0.001.10 Cryotherapy allowed for a greater reduction in
BASDAI, though no p-value analysis was done for this difference. Disease activity in the
cryotherapy group was also still significantly reduced at 3 months post trial with a p-value of <
0.001, which was not the case for the conventional exercise therapy group.10 Results can be
found in Table 4.
Table 4. BASDAI Change in Disease Activity Before and After Intervention10
Group
Before
After
3-months post
Mean
P-value
Intervention Intervention
Intervention Change from
Baseline
(Mean ± SD) (Mean ± SD) (Mean ± SD)
WBC +
2.76
< 0.001
8.72 ± 3.42
5.96 ± 3.64
6.76 ± 3.07
exercise therapy
Exercise
- 1.66
< 0.001
9.36 ± 4.31
7.70 ± 4.43
8.88 ± 4.13
therapy alone
Comparison
1.1
N/A
after
intervention
Mean change from baseline was calculated between before intervention and after intervention BASDAI only. P-value was
calculated using these values.

Discussion
Ankylosing spondylitis is a debilitating musculoskeletal autoimmune disease with limited
safe and effective long term treatment options. This review compares three RCTs investigating
the potential benefit of adding cryotherapy in addition to exercise therapy to the current accepted
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treatment guidelines for patients with AS. In all three studies, cryotherapy demonstrated
significant reduction in symptomatic disease activity experienced by the patient, as measured
using the BASDAI, in comparison to exercise therapy alone.
Stanek et al. demonstrated the greatest reduction in BASDAI as a result of cryotherapy
compared to the control group, difference between BASDAI being 1.4 with a p-value of 0.001.
Straburzyńska-Lupa et al. demonstrated statistical significance of cryotherapy over exercise
therapy as well, although the difference in BASDAI was not as large at 0.39, and a p-value of
0.041, raising doubt of the clinical significance. Księżopolska-Orłowska et al. demonstrated that
cryotherapy resulted in not only a significant reduction in BASDAI directly post-trial but also at
3 months post-trial, with a p-value of < 0.001. The control group for this study demonstrated
statistical significance directly post-trial only.
Some limitations are apparent in the reviewed studies. Due to the nature of the
intervention in question, participants in all three studies were unable to be blinded to their
intervention. This can lead to bias when participants are reporting their symptomatic disease
activity at the end each trial. There were also relatively small sample sizes in each study,
bringing to question the validity and reproducibility of the results. Another limitation to note is
minor discrepancies between the studies. Regarding pharmacologic regimen throughout the
duration of the study, Straburzyńska-Lupa et al. had participants refrain from all medications
besides NSAIDs, while Stanek had participants on a steady regimen DMARDs, and
Księżopolska-Orłowska had no strict guidelines, including participants on either DMARDs,
NSAIDs, or biologic agents. The use of different pharmacologic agents during the study could
impact how participants respond to cryotherapy or exercise therapy. Regarding cryotherapy
protocol, Księżopolska-Orłowska et al. failed to report the means or duration by which systemic
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comparison their results are. Regarding patient demographics, Straburzyńska-Lupa et al.
included female and male patients while the other two studies included males only. However, the
inclusion of female participants helps to increase generalizability of the intervention.
Conclusion
Based on the three studies considered in this review, cryotherapy in addition to exercise
therapy has proven to be more effective than exercise therapy alone in reducing the symptoms of
ankylosing spondylitis. However, future studies are warranted to confirm reliability and validity
of these results considering the several limitations. Future studies should include comparison of
patients on different regimens of pharmacologic treatment while undergoing cryotherapy, to
confirm effectiveness of this intervention despite differences in medications and explored
whether pharmacotherapy could potentially be reduced. Future research should also use larger
sample sizes and include farther out analysis of the effects of cryotherapy to determine the
longevity of the results and whether maintenance therapy is required. Despite the limitations of
the reviewed studies, systemic cryotherapy shows potential as a therapeutic intervention for
ankylosing spondylitis.
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